Haemostatic changes related to fibrin formation and fibrinolysis during the first trimester in normal pregnancy and in current miscarriage

Thrombosis and Haemostasis

Volumn 97, Issue 4, 2007, Pages 552-557

  Cappelletti, Rita Marchi ^a   Ramirez, Ysabel López ^a   Nagaswami, Chandrasekaran ^b   Masova, Leona ^b   Pulido, Anibal ^c   Mora, José López ^c   Muller, Aixa ^c   Arocha Piñango, Carmen Luisa ^a   Weisel, John W ^b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

Author keywords

Clot structure; Internal fibrin lysis; Pregnancy; Recurrent miscarriage; Rheological properties

Indexed keywords

FIBRIN; FIBRINOGEN; MONOMER; PHOSPHOLIPID ANTIBODY;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; FIRST TRIMESTER PREGNANCY; FLOW KINETICS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; SPONTANEOUS ABORTION; TURBIDITY; VOLUNTEER;

ABORTION, HABITUAL; BLOOD COAGULATION TESTS; FEMALE; FIBRIN; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NEPHELOMETRY AND TURBIDIMETRY; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTER, FIRST; THROMBELASTOGRAPHY; TIME FACTORS; VENEZUELA;

EID: 34247119791     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-09-0542     Document Type: Article

References (46)

1. Stirling Y, et al. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-182.
2. Kjellberg U, et al. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527-531.
3. Cerneca F, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73: 31-36.
4. Clark P et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170.
5. Clark P. Changes of hemostasis variables during pregnancy. Semin Vasc Med 2003; 3: 13-24.
6. Condie RG. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia. Br J Obstet Gynaecol 1976; 83: 636-639.
7. Lindoff C, et al. Fibrinolytic components in individual consecutive plasma samples during normal pregnancy. Fibrinolysis 1993; 7: 190-194.
8. Chabloz P, et al. TAF1 antigen and D-dimer levels during normal pregnancy and at delivery. Br J Haematol 2001; 115: 150-152.
9. Wright JG, et al. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. Br J Haematol 1988; 69: 253-258.
10. Phillips LL, et al. Changes in plasma factor XI (plasma thromboplastin antecedent) levels during pregnancy. Am J Obstet Gynecol 1973; 116: 1114-1116.
11. Hayano Y, et al. Studies on the physiological changes of blood coagulation factor XIII during pregnancy and their significance. Nippon Sanka Fujinka Gakkai Zasshi 1982; 34: 469-477.
12. Espana F, et al. Complexes of activated protein C with alpha l-antitrypsin in normal pregnancy and in severe preeclampsia. Am J Obstet Gynecol 1991; 164: 1310-1316.
13. Letkowitz JB, et al. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 1996; 175: 657-660.
14. Hayashi M, et al. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. Eur J Haematol 2002; 69: 297-302.
15. Delorme MA, et al. Thrombin regulation in mother and fetus during pregnancy. Semin Thromb Hemost 1992; 18: 81-90.
16. Bremme K, et al. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992; 80: 132-137.
17. Reinthaller A, et al. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery. Br J Obstet Gynaecol 1990; 97: 506-510.
18. Ayhan A, et al. Beta-thromboglobulin and platelet factor 4 levels in pregnancy and preeclampsia. Gynecol Obstet Invest 1990; 30: 12-14.
19. Bellart J, et al. Endothelial cell markers and fibrino-peptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998; 46: 17-2 1.
20. Holmes VA, Wallace JM. Haemostasis in normal pregnancy: a balancing act? Biochem, Soc Trans 2005; 33: 428-432.
21. Bick RL. Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects. Hematol Oncol Clin North Am 2000; 14: 1117-1131.
22. Bick RL, Hoppensteadt D. Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update. Clin Appl Thromb, Hemost 2005; 11: 1-13.
23. Dossenbach-Glaninger A, et al. Plasminogen activator inhibitor I 4G/ 5G polymorphism and coagulation factor XIII Val34Leu polymorphism: Impaired fibrinolysis and early pregnancy loss. Clin Chem 2003; 49: 1081-1086.
24. Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Sem Thromb Hemost 2003; 29: 171-174.
25. Frenkel E, et al. Congenital hypofibrinogenemia in pregnancy: report of two cases and review of the literature. Obstet Gynecol Surv 2004; 59: 775-779.
26. Kumar M, Mehta P. Congenital coagulopathies and pregnancy: Report of four pregnancies in a factor X-deficient woman. Am J Hematol 1994; 46: 241-244.
27. Valnicek S, et al. Hemotherapeutic safeguarding of induced abortion in inborn proconvertin insufficiency (hemagglutination factor VII) using exchange plasma-pheresis. Zentralbl Gynakol 1972; 94: 931-935.
28. Bick RL, Baker WF, Antiphospholipid syndrome and thrombosis. Semin Thromb Hemost 1999; 25: 333-350.
29. Schved JF, et al. Factor XII congenital deficiency and early spontaneous abortion. Fertil Steril 1989; 52: 335-336.
30. Klein M, et al. Obstetrical management of dysfibrinogenemia with increased thrombophilia. Geburtshilfe Frauenheilkd 1992; 52: 442-444.
31. Barkagan ZS, Belykh SI. Protein C deficiency and the multi-thrombotic syndrome associated with pregnancy and abortion. Gematol Transfuziol 1992; 37: 35-37.
32. Hellgren M, et al. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest 1982; 14: 127-141.
33. Simioni P et al. Hereditary heparin cofactor II deficiency and trombosis: report of six patients belonging to two separate kindreds. Blood Coagul Fibrinolysis 1990; 1: 351-356.
34. Gris JC, et al. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology. J Lab Clin Med 1993; 122: 606-615.
35. Glueck CJ, et al. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 1999; 48: 1589-1595.
36. Ingram GIC. The determination of plasma fibrinogen by the clot weight method. Biochem J 1952; 51: 583-585.
37. Blombäck B, Okada M. Fibrin gel structure and clotting time. Thromb Res 1982; 25: 51-70.
38. Janmey PA. A torsion pendulum for measurement of the viscoelasticity of biopolymers and its application to actin networks. J Biochem Biophys Methods 1991; 22: 41-53.
39. Lopez Ramirez Y, et al. Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage. Clin Chim Acta 2006; 374: 69-74.
40. Langer BG, et al. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem 1988; 263: 15056-15063.
41. Ebert RF. Index of variant human fibrinogens, CRC Press Boca Raton, 1991.
42. Gralnick HR, et al. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule. N Engl J Med 1978; 299: 221-226.
43. Weisel JW Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. Biophys J 1992; 63: 111-128.
44. Maghzal GJ, et al. The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapy. Thromb Res 2005; 115: 293-299.
45. Schubring C, et al. Fibrinolysis and factor XIII in women with spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 1990; 35: 215-221.
46. Rai R, et al. Thromboelastography, whole blood haemostasis and recurrent miscarriage. Hum Reprod 2003; 18: 2540-2543.